|
Index of reports
> Cases with Renal Impairment (71)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) where reactions include renal impairment. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 71 Next >>
Possible Neoral side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient: 25 year old female
Reactions: Pseudomonas Infection, Nephropathy Toxic, Lung Transplant Rejection, Toxicity To Various Agents, Respiratory Distress, Renal Failure, COR Pulmonale Acute, Renal Impairment, Overdose, Lung Disorder, Pulmonary Oedema, Hypoxia, Acute Respiratory Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Targocid
Dosage: unk
End date: 2012-01-23
Previgen
Dosage: 100 mg/ml, unk
End date: 2012-01-24
Neoral
Dosage: 75 mg, bid
Indication: Lung Transplant
Start date: 2009-11-01
End date: 2012-01-23
Other drugs received by patient: Boniva; Vitamin D; Neorecormon; Flecainide Acetate; Propyl-Thiouracil; Ceftazidime; Creon; Tenormin; Olimel; Venofer; Zithromax; Prednisone TAB; Ursolvan; Chlormadinone Acetate TAB; Lantus; Atarax; Ciprofloxacin Hydrochloride
Possible Neoral side effects in male
Reported by a consumer/non-health professional from Italy on 2012-08-08
Patient: male
Reactions: Nephrolithiasis, Renal Impairment
Drug(s) suspected as cause:
Neoral
Possible Neoral side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-06
Patient: male, weighing 52.0 kg (114.4 pounds)
Reactions: Back Pain, Drug Resistance, Blood Triglycerides Increased, General Physical Health Deterioration, Neoplasm Progression, C-Reactive Protein Decreased, Kidney Transplant Rejection, Renal Failure Chronic, Post Transplant Lymphoproliferative Disorder, Renal Impairment
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 2.75 mg, unk
Administration route: Oral
Start date: 2007-07-28
End date: 2007-10-07
Prograf
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2001-01-01
End date: 2006-12-01
Prograf
Dosage: 3 mg, unk
Administration route: Oral
Start date: 2008-08-01
End date: 2008-08-22
Certican
Dosage: 2.75 mg, unk
Administration route: Oral
Start date: 2008-09-07
End date: 2008-09-27
Certican
Dosage: 4 mg, unk
Administration route: Oral
Start date: 2009-07-19
Neoral
Dosage: unk ukn, unk
Indication: Renal Transplant
Start date: 2001-01-01
End date: 2006-01-01
Certican
Dosage: 3 mg, unk
Administration route: Oral
Start date: 2007-07-24
End date: 2007-07-27
Certican
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2008-08-25
End date: 2008-09-06
Prograf
Dosage: 4 mg, unk
Administration route: Oral
Start date: 2002-02-19
End date: 2007-07-12
Prograf
Dosage: 2.25 mg, unk
Administration route: Oral
Start date: 2008-08-23
End date: 2008-08-25
Certican
Dosage: 3 mg, unk
Administration route: Oral
Start date: 2009-06-06
End date: 2009-07-18
Certican
Dosage: 4.25 mg, daily
Administration route: Oral
Start date: 2009-08-22
End date: 2009-09-03
Certican
Dosage: 2 mg, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 2007-07-13
End date: 2007-07-23
Certican
Dosage: 1.75 mg, unk
Start date: 2008-08-01
End date: 2008-08-24
Certican
Dosage: 4.75 mg, unk
Administration route: Oral
Start date: 2009-11-13
End date: 2010-03-02
Prednisolone
Dosage: 5 mg, unk
Administration route: Oral
Start date: 2008-07-30
Certican
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2007-10-08
Certican
Dosage: 3.25 mg, unk
Administration route: Oral
Start date: 2008-09-28
End date: 2009-06-05
Prograf
Dosage: 0.5 mg, unk
Administration route: Oral
Start date: 2007-07-13
Certican
Dosage: 4.5 mg, daily
Administration route: Oral
Start date: 2009-09-04
End date: 2009-11-12
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 1995-01-01
End date: 2001-01-01
Prograf
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2008-07-29
End date: 2008-07-30
Prograf
Dosage: 1.5 mg, unk
Administration route: Oral
Start date: 2008-09-28
End date: 2008-10-02
Certican
Dosage: 1.25 mg, unk
Administration route: Oral
Start date: 2008-07-30
End date: 2008-07-30
Prograf
Dosage: 2 mg, unk
Administration route: Oral
Start date: 2008-08-26
End date: 2008-09-27
Other drugs received by patient: Mycophenolate Mofetil; Chemotherapeutics NOS; Pravastatin Sodium; Trandolapril; Prednisolone; Mycophenolate Mofetil; Steroids NOS; Pravastatin Sodium; Azathioprine Sodium; Candesartan Cilexetil; Mycophenolate Mofetil; Tacrolimus
Possible Neoral side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-06
Patient: male, weighing 52.0 kg (114.4 pounds)
Reactions: Back Pain, Drug Resistance, Blood Triglycerides Increased, General Physical Health Deterioration, Neoplasm Progression, C-Reactive Protein Decreased, Kidney Transplant Rejection, Renal Failure Chronic, Post Transplant Lymphoproliferative Disorder, Renal Impairment
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 2 mg, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 2007-07-13
End date: 2007-07-23
Certican
Dosage: 3 mg, unk
Administration route: Oral
Start date: 2007-07-24
End date: 2007-07-27
Prograf
Dosage: 3 mg, unk
Administration route: Oral
Start date: 2008-08-01
End date: 2008-08-22
Certican
Dosage: 1.75 mg, unk
Start date: 2008-08-01
End date: 2008-08-24
Certican
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2008-08-25
End date: 2008-09-06
Neoral
Dosage: unk ukn, unk
Indication: Renal Transplant
Start date: 2001-01-01
End date: 2006-01-01
Certican
Dosage: 2.75 mg, unk
Administration route: Oral
Start date: 2007-07-28
End date: 2007-10-07
Certican
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2007-10-08
Certican
Dosage: 3.25 mg, unk
Administration route: Oral
Start date: 2008-09-28
End date: 2009-06-05
Certican
Dosage: 3 mg, unk
Administration route: Oral
Start date: 2009-06-06
End date: 2009-07-18
Certican
Dosage: 4.75 mg, unk
Administration route: Oral
Start date: 2009-11-13
End date: 2010-03-02
Prograf
Dosage: 2.25 mg, unk
Administration route: Oral
Start date: 2008-08-23
End date: 2008-08-25
Prograf
Dosage: 2 mg, unk
Administration route: Oral
Start date: 2008-08-26
End date: 2008-09-27
Certican
Dosage: 4.25 mg, daily
Administration route: Oral
Start date: 2009-08-22
End date: 2009-09-03
Certican
Dosage: 4.5 mg, daily
Administration route: Oral
Start date: 2009-09-04
End date: 2009-11-12
Prednisolone
Dosage: 5 mg, unk
Administration route: Oral
Start date: 2008-07-30
Prograf
Dosage: 4 mg, unk
Administration route: Oral
Start date: 2002-02-19
End date: 2007-07-12
Prograf
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2008-07-29
End date: 2008-07-30
Certican
Dosage: 2.75 mg, unk
Administration route: Oral
Start date: 2008-09-07
End date: 2008-09-27
Prograf
Dosage: 1.5 mg, unk
Administration route: Oral
Start date: 2008-09-28
End date: 2008-10-02
Certican
Dosage: 1.25 mg, unk
Administration route: Oral
Start date: 2008-07-30
End date: 2008-07-30
Certican
Dosage: 4 mg, unk
Administration route: Oral
Start date: 2009-07-19
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 1995-01-01
End date: 2001-01-01
Prograf
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2001-01-01
End date: 2006-12-01
Prograf
Dosage: 0.5 mg, unk
Administration route: Oral
Start date: 2007-07-13
Other drugs received by patient: Prednisolone; Tacrolimus; Mycophenolate Mofetil; Mycophenolate Mofetil; Azathioprine Sodium; Chemotherapeutics NOS; Trandolapril; Steroids NOS; Pravastatin Sodium; Mycophenolate Mofetil; Pravastatin Sodium; Candesartan Cilexetil
Possible Neoral side effects in female
Reported by a health professional (non-physician/pharmacist) from Argentina on 2012-07-26
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Renal Impairment, Bacteraemia, Ischaemic Stroke, Urinary Tract Infection, Dehydration, Septic Shock, Cardiac Arrest
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Myfortic
Dosage: 720 mg, bid
Administration route: Oral
Start date: 2011-12-16
End date: 2012-01-24
Neoral
Dosage: unk
Indication: Renal Transplant
Start date: 2012-01-26
End date: 2012-01-28
Prograf
Dosage: 10 mg, unk
Administration route: Oral
Prograf
Dosage: 4 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-12-16
End date: 2012-01-25
Possible Neoral side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-16
Patient: 69 year old male
Reactions: Generalised Oedema, Weight Increased, Renal Impairment, Neoplasm Malignant, Gastrointestinal Disorder, Bone Marrow Failure, Pleural Effusion, Fluid Retention, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Possible Neoral side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-09
Patient: female, weighing 39.0 kg (85.8 pounds)
Reactions: Renal Impairment, Pneumonia, Cardiac Failure, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Exjade
Dosage: 1000 mg, daily
Administration route: Oral
Indication: Iron Overload
Start date: 2009-05-27
End date: 2009-07-07
Neoral
Indication: Myelodysplastic Syndrome
Neoral
Dosage: 100 mg, daily
Administration route: Oral
Indication: Iron Overload
Start date: 2009-05-27
End date: 2009-11-24
Exjade
Dosage: 725 mg, daily
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2009-09-30
End date: 2009-11-24
Other drugs received by patient: Blood Transfusion, Auxiliary Products; Primobolan-Depot INJ; Prednisolone Sodium Succinate INJ; RED Blood Cells, Concentrated; RED Blood Cells, Concentrated
Possible Neoral side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-06
Patient: female, weighing 48.0 kg (105.6 pounds)
Reactions: Hydronephrosis, Maternal Exposure During Pregnancy, Urinary Tract Infection, Pyrexia, Premature Labour, Device Occlusion, Renal Impairment, Ureteral Spasm, C-Reactive Protein Increased, Blood Creatinine Increased, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Antihypertensives; Bredinin; Allopurinol; Diovan; Medrol; Imuran; Prednisolone Sodium Succinate INJ
Possible Neoral side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-06
Patient: 51 year old female
Reactions: RED Blood Cell Abnormality, Blood Lactate Dehydrogenase Increased, Platelet Count Increased, Anxiety, Renal Impairment, Platelet Count Decreased, Renal Tubular Necrosis, Haemolytic Uraemic Syndrome, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 400 mg, daily
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-06-08
End date: 2010-06-09
Sandimmune
Dosage: 200 mg, daily
Start date: 2010-06-11
End date: 2010-06-11
Sandimmune
Dosage: 175 mg, daily
Indication: Renal Transplant
End date: 2010-06-11
Other drugs received by patient: Cefaclor; Adalat; Atarax; Pancreaze; Gamofa; Prednisolone Sodium Succinate INJ; Prograf; Tacrolimus; Amlodipine; Sucralfate; Alosenn; Gamofa; Prednisolone Sodium Succinate INJ; Prednisolone Sodium Succinate INJ; Prograf; Prograf; Allegra; Doxazosin Mesylate; Cefazolin Sodium; Nicardipine HCL; Simulect; Simulect; Doxazosin Mesylate; Aspirin; Sodium Picosulfate; Rabeprazole Sodium; Prednisolone Sodium Succinate INJ; Prednisolone Sodium Succinate INJ; Lasix; Spanidin; Venilon; Cellcept; Nafamostat; Medrol; Carvedilol; Alosenn; Buscopan
Possible Neoral side effects in male
Reported by a physician from Japan on 2012-06-18
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Urine Output Decreased, Pancytopenia, Condition Aggravated, Pyrexia, Ascites, Renal Failure, Renal Impairment, Hepatic Cirrhosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neoral
Dosage: 420 mg, qd
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2012-04-13
End date: 2012-04-19
Neoral
Dosage: 250 mg, qd
Administration route: Oral
Start date: 2012-04-20
End date: 2012-04-20
Neoral
Dosage: 125 mg, unk
Administration route: Oral
Start date: 2012-05-10
End date: 2012-05-10
Neoral
Dosage: 75 mg, unk
Administration route: Oral
Start date: 2012-05-11
End date: 2012-05-13
Neoral
Dosage: 150 mg, unk
Administration route: Oral
Start date: 2012-04-21
End date: 2012-05-09
Other drugs received by patient: Adrenal Hormone Preparations; Omeprazole; Primobolan-Depot INJ; Diflucan; Losartan Potassium; Sodium Chloride; Corticosteroid NOS; Pursennid; Gran; Pyrinazin; Solu-Medrol; Thymoglobulin; Lactec; Lactec; Omeprazole; Valtrex
Possible Neoral side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18
Patient: 65 year old male
Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone; Oxygen
Possible Neoral side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18
Patient: 65 year old male
Reactions: Portal Hypertension, Polyarteritis Nodosa, Hepatic Function Abnormal, Hepatic Failure, Pulmonary Fibrosis, Ascites, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Hepatic Cirrhosis, Arterial Stenosis, Necrosis of Artery
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone; Oxygen
Possible Neoral side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18
Patient: 65 year old male
Reactions: Portal Hypertension, Hepatic Function Abnormal, Polyarteritis Nodosa, Hepatic Failure, Ascites, Pulmonary Fibrosis, Renal Impairment, Interstitial Lung Disease, Nodular Regenerative Hyperplasia, Chronic Hepatitis, Necrosis of Artery, Hepatic Cirrhosis, Arterial Stenosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone; Oxygen
Possible Neoral side effects in male
Reported by a pharmacist from Japan on 2012-06-14
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Urine Output Decreased, Condition Aggravated, Pancytopenia, Pyrexia, Ascites, Renal Failure, Renal Impairment, Hepatic Cirrhosis
Drug(s) suspected as cause:
Neoral
Dosage: 250 mg, qd
Administration route: Oral
Start date: 2012-04-20
End date: 2012-04-20
Neoral
Dosage: 125 mg, unk
Administration route: Oral
Start date: 2012-05-10
End date: 2012-05-10
Neoral
Dosage: 150 mg, unk
Administration route: Oral
Start date: 2012-04-21
End date: 2012-05-09
Neoral
Dosage: 420 mg, qd
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2012-04-13
End date: 2012-04-19
Neoral
Dosage: 75 mg, unk
Administration route: Oral
Start date: 2012-05-11
End date: 2012-05-13
Other drugs received by patient: Omeprazole; Lactec; Adrenal Hormone Preparations; Primobolan-Depot INJ; Sodium Chloride; Thymoglobulin; Diflucan; Valtrex; Losartan Potassium; Lactec; Gran; Corticosteroid NOS; Omeprazole; Pyrinazin; Pursennid; Solu-Medrol
Possible Neoral side effects in female
Reported by a physician from Japan on 2012-06-07
Patient: female, weighing 13.0 kg (28.6 pounds)
Reactions: Nasopharyngitis, Nausea, Pyrexia, Respiratory Syncytial Virus Infection, Renal Impairment, Diarrhoea, Interstitial Lung Disease, Heart Transplant Rejection, Rash Erythematous, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prograf
Dosage: 4.5 mg, unk
Administration route: Oral
Start date: 2006-01-23
End date: 2006-02-16
Certican
Dosage: 1 mg, unk
Administration route: Oral
Start date: 2006-01-30
End date: 2006-02-03
Certican
Dosage: 0.75 mg, unk
Administration route: Oral
Start date: 2006-02-03
End date: 2006-04-24
Certican
Dosage: 0.5 mg, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 2006-01-23
End date: 2006-01-30
Neoral
Indication: Heart Transplant
Cellcept
Administration route: Oral
Indication: Heart Transplant
Start date: 2009-02-01
Certican
Dosage: 1 mg, daily
Administration route: Oral
Start date: 2008-01-23
End date: 2009-01-22
Azathioprine
Administration route: Oral
Indication: Heart Transplant
Tacrolimus
Indication: Heart Transplant
Prograf
Dosage: 4.8 mg, unk
Administration route: Oral
Indication: Heart Transplant
End date: 2006-01-23
Prograf
Dosage: 4.0 mg, unk
Administration route: Oral
Start date: 2006-03-20
End date: 2006-04-24
Certican
Dosage: unk
Administration route: Oral
End date: 2009-02-05
Certican
Dosage: unk
Prograf
Dosage: 3.0 mg, unk
Administration route: Oral
Start date: 2006-02-16
End date: 2006-03-20
Other drugs received by patient: Everolimus; Tenormin; Sirolimus; Famotidine
Possible Neoral side effects in female
Reported by a physician from Japan on 2012-05-22
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Renal Impairment, Hepatic Function Abnormal, Blood Creatinine Increased, Serum Ferritin Increased, Gastritis
Drug(s) suspected as cause:
Neoral
Dosage: 200 mg, daily
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2005-08-02
Exjade
Dosage: 500 mg, daily
Administration route: Oral
Indication: Iron Overload
Start date: 2009-09-08
End date: 2009-11-09
Exjade
Dosage: 500 mg, daily
Administration route: Oral
Start date: 2009-11-10
Neoral
Dosage: 200 mg, daily
Administration route: Oral
Other drugs received by patient: Primobolan-Depot INJ; Norvasc; Norvasc; Allopurinol; Allopurinol; RED Blood Cells, Concentrated
Possible Neoral side effects in 77 year old male
Reported by a physician from Japan on 2012-05-21
Patient: 77 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Renal Impairment, Hyperuricaemia, Disease Progression
Drug(s) suspected as cause:
Exjade
Dosage: 500 mg, qw3
Administration route: Oral
Indication: Iron Overload
Start date: 2011-01-12
End date: 2011-09-21
Neoral
Dosage: 300 mg, daily
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2011-01-12
End date: 2011-02-16
Neoral
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2011-02-17
End date: 2011-04-20
Exjade
Dosage: 500 mg, qw5
Administration route: Oral
Start date: 2011-09-21
End date: 2012-01-12
Neoral
Dosage: 200 mg,daily
Administration route: Oral
Start date: 2011-04-21
End date: 2012-01-12
Other drugs received by patient: Magmitt Kenei; RED Blood Cells, Concentrated; Allopurinol; RED Blood Cells, Concentrated; Gasmotin; Lasix
Possible Neoral side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-18
Patient: female, weighing 47.0 kg (103.4 pounds)
Reactions: Renal Impairment, Nausea, Cerebral Haemorrhage, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Dosage: 150 mg, unk
Administration route: Oral
Start date: 2009-05-13
End date: 2009-06-09
Exjade
Dosage: 1000 mg, unk
Administration route: Oral
Indication: Iron Overload
Start date: 2008-08-07
End date: 2008-08-20
Exjade
Dosage: 1000 mg, unk
Administration route: Oral
Start date: 2008-10-02
End date: 2010-05-03
Neoral
Dosage: 75 mg, unk
Administration route: Oral
Start date: 2008-11-06
End date: 2008-12-17
Neoral
Dosage: 125 mg, unk
Administration route: Oral
Start date: 2009-06-10
End date: 2009-08-26
Exjade
Dosage: 500 mg, unk
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2008-08-21
End date: 2008-10-01
Neoral
Dosage: 100 mg, unk
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2003-06-01
End date: 2008-11-05
Neoral
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2008-12-18
End date: 2009-05-12
Other drugs received by patient: Adona; Levofloxacin; Blood Cells, Packed Human; Desferal; Lipitor; Mucosta; Neutrogin; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human; Transamine CAP; Glakay; Maxipime; Blood Cells, Packed Human; Amlodipine Besylate; Ampicillin; Norvasc; Lasoprazole; Blood Cells, Packed Human; Sulbactam Sodium; Onealfa; Tranexamic Acid; Blood Cells, Packed Human; Blood Cells, Packed Human; Blood Cells, Packed Human
Possible Neoral side effects in male
Reported by a consumer/non-health professional from Denmark on 2012-04-30
Patient: male
Reactions: Complications of Transplanted Kidney, Renal Disorder, Gout, Kidney Fibrosis, Osteopenia, Nephrosclerosis, Blood Calcium Decreased, Vascular Calcification, Osteonecrosis, Renal Impairment, Arthralgia, Blood Uric Acid Increased, Spinal Osteoarthritis, Renal Graft Loss
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Rapamune; Mycophenolate Mofetil (Cellcept); Myfortic; Prednisolone
Possible Neoral side effects in female
Reported by a physician from United States on 2012-04-27
Patient: female
Reactions: Abdominal Discomfort, Renal Impairment, Diarrhoea, Dehydration, Flatulence, Urinary Bladder Rupture, Open Wound, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Possible Neoral side effects in 25 year old male
Reported by a consumer/non-health professional from Japan on 2012-04-23
Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Itraconazole
Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-06-06
End date: 2009-07-16
Foscavir
Dosage: form:inj1 df= 10 unit nos
Start date: 2009-07-10
End date: 2009-07-16
Bactrim
Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
Administration route: Oral
Indication: Antibiotic Prophylaxis
Start date: 2009-04-14
End date: 2009-07-16
Farom
Administration route: Oral
Start date: 2009-04-28
End date: 2009-05-01
Neoral
Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-04-14
End date: 2009-07-08
Sprycel
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-16
End date: 2009-07-08
Maxipime
Start date: 2009-04-24
End date: 2009-04-27
Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone
Possible Neoral side effects in male
Reported by a physician from France on 2012-04-20
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Bronchial Obstruction, Klebsiella Infection, Thrombocytopenia, Post Procedural Haemorrhage, Escherichia Sepsis, Renal Vessel Disorder, Complications of Transplanted Kidney, Wound Dehiscence, Anaemia, Malnutrition, Anastomotic Haemorrhage, Wound Complication, Renal Impairment, Diarrhoea, Cytomegalovirus Infection, Renal Tubular Necrosis, Pneumonia Escherichia, Asthenia, Leukopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2011-02-10
Mycophenolate Mofetil (Cellcept)
Dosage: 1 g, per day
Administration route: Oral
Start date: 2011-03-01
End date: 2011-03-08
Bactrim
Dosage: 400 mg, per day
Administration route: Oral
Start date: 2011-01-24
End date: 2011-02-01
RAD 666 / RAD 001a
Dosage: 3 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-02-02
End date: 2011-02-09
Neoral
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2011-02-27
End date: 2011-03-16
Neoral
Dosage: unk
Mycophenolate Mofetil (Cellcept)
Dosage: 2 g, per day
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-15
End date: 2011-02-09
Neoral
Dosage: 400 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-17
End date: 2011-02-01
Prednisone TAB
Dosage: 40 mg, per day
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-16
Zantac
Dosage: 150 mg, per day
Administration route: Oral
Start date: 2011-02-02
Valganciclovir
Dosage: 250 mg, 9qd
Administration route: Oral
Start date: 2011-01-29
End date: 2011-02-01
Nexium
Dosage: 40 mg, per day
Administration route: Oral
Start date: 2011-01-16
End date: 2011-02-01
Other drugs received by patient: Solu-Medrol; Lasix; Adancor; Esomeprazole Magnesium; Calcidia; Pantoprazole; Aspirin; Sodium Bicarbonate; Amlodipine Besylate; Econazole Nitrate; Amoxicillin; Imodium; Simulect; Eprex; Insulatard NPH Human; Potassium Chloride; Nitroderm; Mirtazapine; Aluminum Hydroxide and Magnesium Trisilicate; Alfuzosin HCL; Cotrim
Possible Neoral side effects in female
Reported by a physician from Japan on 2012-04-19
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Pyrexia, Rash, Kidney Transplant Rejection, Urine Abnormality, Hypokinesia, Renal Impairment, Cytomegalovirus Infection, Pneumonia Staphylococcal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simulect
Dosage: 20 mg, once/single
Indication: Renal Transplant
Start date: 2010-01-20
End date: 2010-01-20
Rituxan
Dosage: 200 mg, unk
Start date: 2010-05-25
Mycophenolate Mofetil (Cellcept)
Dosage: 1800 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-01-06
End date: 2010-01-19
Mycophenolate Mofetil (Cellcept)
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2010-01-24
Mycophenolate Mofetil (Cellcept)
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2010-01-21
Neoral
Dosage: 300 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-01-17
End date: 2010-01-19
Neoral
Dosage: 200 mg
Administration route: Oral
Start date: 2010-03-02
End date: 2010-10-03
Neoral
Dosage: 150 mg, unk
Administration route: Oral
Start date: 2010-10-04
Prednisolone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-01-24
End date: 2010-01-25
Prednisolone
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2010-01-29
End date: 2010-01-30
Simulect
Dosage: 20 mg, once/single
Start date: 2010-01-24
End date: 2010-01-24
Neoral
Dosage: 300 mg, qd
Start date: 2010-01-23
End date: 2010-02-06
Neoral
Dosage: 150 mg, unk
Start date: 2011-01-24
End date: 2011-10-12
Neoral
Dosage: 250 mg, qd
Administration route: Oral
Start date: 2010-02-07
End date: 2010-03-01
Neoral
Dosage: 100 mg, unk
Start date: 2011-10-13
Sandimmune
Dosage: 100 mg, unk
Indication: Renal Transplant
Start date: 2010-01-20
End date: 2010-01-22
Prednisolone
Dosage: 30 mg, unk
Administration route: Oral
Start date: 2010-01-26
End date: 2010-01-28
Prednisolone
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2010-01-31
Rituxan
Dosage: 200 mg, unk
Indication: Kidney Transplant Rejection
Start date: 2010-01-13
End date: 2010-01-13
Other drugs received by patient: Spanidin; Solu-Medrol; Adalat CC; Adalat; Solu-Medrol
Possible Neoral side effects in male
Reported by a physician from Japan on 2012-04-18
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Pneumonia, Renal Impairment, Neoplasm Malignant, Platelet Count Increased, Neoplasm Progression, Pyrexia, Upper Respiratory Tract Inflammation, White Blood Cell Count Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Exjade
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2011-03-10
End date: 2011-06-20
Neoral
Dosage: 20 mg, daily
Administration route: Oral
Start date: 2010-10-15
End date: 2010-10-21
Ambisome
Dosage: 140 mg, daily
Start date: 2011-07-05
End date: 2011-07-20
Exjade
Dosage: 125 mg daily
Administration route: Oral
Start date: 2011-03-01
End date: 2011-03-08
Neoral
Dosage: 200 mg, daily
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2010-08-03
End date: 2010-09-27
Exjade
Dosage: 1500 mg,daily
Administration route: Oral
Indication: Iron Overload
Start date: 2010-08-03
End date: 2010-08-09
Exjade
Dosage: 500 mg, daily
Administration route: Oral
Start date: 2010-09-07
End date: 2010-10-15
Ambisome
Dosage: 140 mg, daily
Start date: 2011-06-10
End date: 2011-06-27
Ambisome
Dosage: 150 mg, daily
Indication: Pneumonia
Start date: 2011-03-01
End date: 2011-03-18
Exjade
Dosage: 625 mg, daily
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2010-08-10
End date: 2010-08-30
Exjade
Dosage: 500 mg, daily
Administration route: Oral
Start date: 2010-08-31
End date: 2010-09-06
Neoral
Dosage: 50 mg, daily
Administration route: Oral
Start date: 2010-10-09
End date: 2010-10-14
Other drugs received by patient: Cotrim; Cotrim; Zolpidem; Rohypnol; Zithromax; Lastet S; RED Cells Concentrated; RED Cells Concentrated; Pursennid; Diflucan; Allopurinol; RED Cells Concentrated; Pursennid; Ciprofloxacin; Hydrea; Allopurinol; Lastet S; Sucralfate; Sucralfate; RED Cells Concentrated; Lansoprazole; Loxonin; Hydrea; RED Cells Concentrated; RED Cells Concentrated; Lansoprazole; Zolpidem; Loxonin; Primobolan-Depot INJ; Lasix; Mucosolvan; RED Cells Concentrated; RED Cells Concentrated; RED Cells Concentrated; Aspirin; Ciprofloxacin; Rohypnol; Lastet S; RED Cells Concentrated; Pursennid; Magnesium Oxide; Cefepime Hydrochloride; RED Cells Concentrated; RED Cells Concentrated; Lansoprazole; Diflucan; Primobolan-Depot INJ; Milmag; Aspirin
Possible Neoral side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 50 year old male
Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased
Drug(s) suspected as cause:
Sandimmune
Dosage: unk ukn, unk
Administration route: Oral
Indication: Erythrodermic Psoriasis
Start date: 1994-01-01
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Psoriasis
Start date: 1994-01-01
End date: 2008-08-01
Neoral
Indication: Erythrodermic Psoriasis
Remicade
Dosage: unk ukn, unk
Indication: Erythrodermic Psoriasis
Start date: 2008-08-01
End date: 2011-05-01
Possible Neoral side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-10
Patient: 50 year old male
Reactions: Renal Impairment, Interstitial Lung Disease, Cell Marker Increased
Drug(s) suspected as cause:
Sandimmune
Dosage: unk ukn, unk
Administration route: Oral
Indication: Erythrodermic Psoriasis
Start date: 1994-01-01
Neoral
Indication: Erythrodermic Psoriasis
Remicade
Dosage: unk ukn, unk
Indication: Erythrodermic Psoriasis
Start date: 2008-08-01
End date: 2011-05-01
Neoral
Dosage: unk ukn, unk
Administration route: Oral
Indication: Psoriasis
Start date: 1994-01-01
End date: 2008-08-01
Possible Neoral side effects in 13 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-06
Patient: 13 year old male
Reactions: Blood Pressure Increased, Vomiting, Nausea, Coma, Blood Albumin Decreased, Headache, Convulsion, Renal Impairment, Visual Impairment, Posterior Reversible Encephalopathy Syndrome
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone
Possible Neoral side effects in male
Reported by a pharmacist from Ireland on 2012-04-02
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Renal Impairment, Nephropathy Toxic, Dehydration, Oedema, Rash, Toxicity To Various Agents, Blood Creatinine Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neoral
Dosage: 150 mg, bid
Indication: Rheumatoid Arthritis
Prograf
Neoral
Indication: Transplant
Tacrolimus
Dosage: 1 df, variable dose target trough 10-12
Start date: 2011-07-14
Tacrolimus
Dosage: 1 df, variable dose target trough 10-12
Start date: 2010-10-14
Tobi
Dosage: 300 mg, bid
Indication: Pseudomonas Infection
Start date: 2011-09-06
End date: 2011-12-01
Other drugs received by patient: Myfortic; Sterimar; Magnesium; Prednisolone; Alfacalcidol; Furosemide; Micera; Lansoprazole; Alendronate Sodium; Nystatin; Azithromycin; Symbicort; Vitamin D; Septin; Folic Acid; Fungizone; Bicarbonate; Chlorhexidine Gluconate; Atorvastatin; Calcium Carbonate; Immunosuppressants
Possible Neoral side effects in male
Reported by a physician from Japan on 2012-03-23
Patient: male
Reactions: Dyspnoea, Hepatic Function Abnormal, Liver Disorder, Renal Impairment, Renal Failure, Cardiac Failure, Respiratory Failure, Heart Rate Increased, Oedema Peripheral, Pleural Effusion, Immunosuppressant Drug Level Increased, Renal Tubular Necrosis, Hypertension, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Allegra; Candesartan Cilexetil; Tigason
Possible Neoral side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-20
Patient: 67 year old female
Reactions: Atelectasis, Lymphadenopathy, Corneal Perforation, Conjunctivitis, Glossitis, Forced Expiratory Volume Decreased, Ulcerative Keratitis, Obliterative Bronchiolitis, Erythema, Alternaria Infection, Skin Ulcer, Lymphocytic Lymphoma, Bronchial Wall Thickening, Bronchospasm, Blister, Stomatitis, Dyspnoea, Pneumonia, Subcutaneous Abscess, Pain of Skin, Rash, Respiratory Distress, Renal Impairment, Respiratory Failure, Fungal Skin Infection, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Neoral
Other drugs received by patient: Prednisolone; Prednisolone
Page 1 Next >>
|
